StockSelector.com
  Research, Select, & Monitor Monday, October 22, 2018 3:26:42 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup

Market Movers
Technicals
Valuations
Growth
  Estimated Earnings
  Historic Earnings
  Estimated Revenue
  Historic Revenue
  Cash
  Dividend
  Shares
Fundamentals
Stock Options

CONCERT PHARMACEUTICALS INC. CNCE 84,541.18% N/A

Concert Pharmaceuticals Inc. is a biopharmaceutical company. It is focused on applying its DCE Platform (R) to create novel small molecule drugs. The Company manufactures drugs in various therapeutic areas such as hot flashes, HIV, renal hepatic, neuropathic pain, MRSA infection, and schizophrenia, multiple tumors, and hyperparathyroidism. Concert Pharmaceuticals Inc. is based in United States.
Company Ticker History Revenue Growth History Growth Rate
Clovis Oncology Inc CLVS 69,287.50% N/A
Paratek Pharmaceuticals Inc. PRTK 41,966.67% N/A
BEIGENE LTD-ADR BGNE 22,179.44% N/A
Akebia Therapeutics AKBA 11,457.14% N/A
Aradigm Corp. ARDM 7,135.00% N/A
GOPHER PROTOCOL GOPH 5,305.88% N/A
Conatus Pharmaceuticals Inc. CNAT 4,322.50% N/A
RedHill Biopharma Ltd. RDHL 3,910.00% N/A
LiveXLive Media, Inc. LIVX 3,030.43% N/A
Sarepta Therapeutics, Inc. SRPT 2,752.03% N/A
Prothena Corporation plc PRTA 2,496.23% N/A
Cerecor, Inc. CERC 2,318.26% N/A
Heron Therapeutics Inc. HRTX 2,303.91% N/A
Ultragenyx Pharmaceutical Inc. RARE 1,907.69% N/A
Innovative Industrial Properties, Inc. IIPR 1,906.25% N/A
FTE Networks, Inc. FTNW 1,883.78% N/A
Senseonics Holdings, Inc. SENS 1,830.30% N/A
Sorrento Therapeutics, Inc. SRNE 1,763.31% N/A
Nano Dimension Ltd. NNDM 1,620.00% N/A
Accelerate Diagnostics Inc AXDX 1,572.00% N/A
Collegium Pharmaceutical Inc. COLL 1,565.50% N/A
Alder Biopharmaceuticals Inc ALDR 1,372.73% N/A
Ramaco Resources, Inc. METC 1,069.35% N/A
Fortress Biotech Inc. FBIO 1,038.23% N/A
Neurocrine Biosciences, Inc. NBIX 977.53% N/A
Summit Therapeutics Plc SMMT 974.03% N/A
Karyopharm Therapeutics Inc KPTI 973.33% N/A
Novelion Therapeutics Inc. NVLN 920.19% N/A
Cara Therapeutics Inc. CARA 911.11% N/A
XOMA Ltd. XOMA 847.66% N/A
Pacific Coast Oil Trust ROYT 781.18% N/A
CRISPR THERAPTC CRSP 694.57% N/A
AMERICAN SURFACE TECHNLGS SURF 668.26% N/A
Dicerna Pharmaceuticals Inc DRNA 660.00% N/A
Cronos Group Inc. CRON 650.00% N/A


Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.